MARKET

GSGTF

GSGTF

Gensight Biologi
EXMKT
3.100
NaN%
Closed 09:30 05/16 EDT
OPEN
--
PREV CLOSE
3.100
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
3.100
MARKET CAP
385.38M
P/E (TTM)
-20.3813
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GSGTF last week (0505-0509)?
Weekly Report · 4d ago
Weekly Report: what happened at GSGTF last week (0428-0502)?
Weekly Report · 05/05 12:00
Weekly Report: what happened at GSGTF last week (0421-0425)?
Weekly Report · 04/28 12:12
Weekly Report: what happened at GSGTF last week (0414-0418)?
Weekly Report · 04/21 12:11
Weekly Report: what happened at GSGTF last week (0407-0411)?
Weekly Report · 04/14 11:57
Weekly Report: what happened at GSGTF last week (0331-0404)?
Weekly Report · 04/07 11:57
Weekly Report: what happened at GSGTF last week (0324-0328)?
Weekly Report · 03/31 12:12
Weekly Report: what happened at GSGTF last week (0317-0321)?
Weekly Report · 03/24 11:56
More
About GSGTF
Gensight Biologics SA is a France-based biopharmaceutical company. The Company develops and commercializes gene therapy-based treatments of retinal degenerative diseases. It develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The Company intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).

Webull offers Gensight Biologics SA stock information, including EXMKT: GSGTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSGTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSGTF stock methods without spending real money on the virtual paper trading platform.